product HOTLINE

Published Online: Saturday, December 1, 2007

Children's Claritin

Children's Claritin, manufactured by Schering- Plough (Kenilworth, NJ), is the only OTC antihistamine currently approved by the FDA for use in children aged 2 and older. The product comes in grape-flavored liquid and chewables for convenient, once-daily dosing. Children?s Claritin is sugar- and alcohol-free and provides all-day allergy relief without restlessness or drowsiness. Each tablet or 5-mL teaspoon of the product contains 5 mg loratadine, which has been proven to provide safe, longlasting relief of the symptoms of allergic rhinitis and seasonal allergies.

For More Information:

HEM-650 BP Monitor

The HEM-650 Wrist Blood Pressure (BP) Monitor with Advanced Positioning Sensor Technology, manufactured by OMRON Healthcare Inc (Bannockburn, Ill), is clinically proven to provide accurate BP and pulse readings, as well as detect irregular heartbeat and hypertension.The product features a large digital display screen and 90 memory recall storage. For information on morning hypertension, please visit

For More Information:


Zicam, manufactured by Matrixx Initiatives Inc (Phoenix, Ariz), is clinically proven to shorten the duration and severity of the common cold. The product does not cause drowsiness, is non?habit-forming, and has no known drug interactions. The product is available in Cold Remedy nasal swabs and Rapid Melts, Cough Max throat spray and melts, Flu formulations that blend with beverages, and nasal sprays for allergy, congestion, and sinus relief. All Zicam Cold Remedy Nasal Gel, Gel Swabs, and oral products contain the active ingredient zincum gluconicum, which has been proven to help patients get over a cold 3 times faster when taken at the first sign of a cold.

For more Information:
877-ZICAM-COLD (877-942-2626)

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues